# Avanos Medical to acquire OrthogenRx for up to $160 million

Avanos Medical Inc. entered into a merger agreement to acquire OrthogenRx, Inc. for $130 million in cash at closing, plus up to $30 million in contingent consideration based on 2022 and 2023 net sales. The merger is expected to close in Q1 2022.

- Type: Acquisition
- Announced: 2021-12-13
- Where: United States
- Value: $130.0M
- Status: announced
- Products: orthopedic products
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Avanos Medical](https://endata.com/companies/41146.md) (acquirer)
- [OrthogenRx](https://endata.com/companies/59676.md) (target)

## Sources

- [marketscreener.com](https://www.marketscreener.com/quote/stock/AVANOS-MEDICAL-INC-44473158/news/AVANOS-MEDICAL-INC-Entry-into-a-Material-Definitive-Agreement-form-8-K-37307441/), 2021-12-13: "The total purchase price payable by the Company in the Merger is $130.0 million in cash at closing, on a cash-free, debt-free basis and subject to adjustments based on the net working capital of OrthogenRx at the closing, plus up to an additional $30.0 million in contingent cash consideration based "

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.